Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.26M Sell
24,164
-40,524
-63% -$2.08M ﹤0.01% 5358
2025
Q4
$3.13M Sell
64,688
-10,648
-14% -$518K ﹤0.01% 4518
2025
Q3
$3.61M Sell
75,336
-29,817
-28% -$1.46M ﹤0.01% 4376
2025
Q2
$5.48M Buy
105,153
+37,226
+55% +$2.06M ﹤0.01% 3781
2025
Q1
$3.92M Sell
67,927
-28,316
-29% -$1.56M ﹤0.01% 4032
2024
Q4
$5.22M Buy
96,243
+75,997
+375% +$4.41M ﹤0.01% 3806
2024
Q3
$1.23M Buy
20,246
+2,370
+13% +$138K ﹤0.01% 4469
2024
Q2
$926K Sell
17,876
-10,738
-38% -$552K ﹤0.01% 4483
2024
Q1
$1.5M Sell
28,614
-3,503
-11% -$176K ﹤0.01% 4230
2023
Q4
$1.69M Buy
32,117
+8,627
+37% +$417K ﹤0.01% 3998
2023
Q3
$1M Sell
23,490
-11,210
-32% -$549K ﹤0.01% 4075
2023
Q2
$1.76M Buy
34,700
+7,466
+27% +$414K ﹤0.01% 3659
2023
Q1
$1.55M Buy
27,234
+4,623
+20% +$247K ﹤0.01% 3690
2022
Q4
$1.16M Buy
22,611
+10,141
+81% +$516K ﹤0.01% 3931
2022
Q3
$580K Buy
12,470
+2,440
+24% +$132K ﹤0.01% 4198
2022
Q2
$589K Sell
10,030
-8,990
-47% -$485K ﹤0.01% 4138
2022
Q1
$948K Buy
19,020
+637
+3% +$31.1K ﹤0.01% 4153
2021
Q4
$845K Buy
18,383
+6,401
+53% +$277K ﹤0.01% 4538
2021
Q3
$513K Buy
11,982
+3,358
+39% +$168K ﹤0.01% 4716
2021
Q2
$456K Sell
8,624
-7,403
-46% -$398K ﹤0.01% 4799
2021
Q1
$733K Sell
16,027
-3,353
-17% -$146K ﹤0.01% 4546
2020
Q4
$858K Buy
19,380
+1,835
+10% +$73.2K ﹤0.01% 4136
2020
Q3
$678K Sell
17,545
-3,308
-16% -$139K ﹤0.01% 3940
2020
Q2
$935K Sell
20,853
-3,524
-14% -$172K ﹤0.01% 3566
2020
Q1
$1.27M Sell
24,377
-7,299
-23% -$432K ﹤0.01% 3145
2019
Q4
$1.96M Buy
31,676
+7,163
+29% +$443K ﹤0.01% 3563
2019
Q3
$1.55M Buy
24,513
+8,063
+49% +$483K ﹤0.01% 3552
2019
Q2
$985K Buy
16,450
+4,171
+34% +$237K ﹤0.01% 3763
2019
Q1
$665K Sell
12,279
-5,037
-29% -$263K ﹤0.01% 3858
2018
Q4
$876K Buy
17,316
+886
+5% +$44.1K ﹤0.01% 3797
2018
Q3
$836K Buy
16,430
+2,173
+15% +$111K ﹤0.01% 4009
2018
Q2
$728K Sell
14,257
-7
-0% -$337 ﹤0.01% 4030
2018
Q1
$662K Sell
14,264
-1,684
-11% -$73.9K ﹤0.01% 4017
2017
Q4
$727K Sell
15,948
-53
-0.3% -$2.66K ﹤0.01% 4025
2017
Q3
$792K Buy
16,001
+1,005
+7% +$50K ﹤0.01% 3885
2017
Q2
$724K Buy
14,996
+272
+2% +$12.9K ﹤0.01% 3858
2017
Q1
$663K Sell
14,724
-3,646
-20% -$164K ﹤0.01% 3845
2016
Q4
$833K Buy
18,370
+4,060
+28% +$169K ﹤0.01% 3700
2016
Q3
$559K Sell
14,310
-2,142
-13% -$88.4K ﹤0.01% 3851
2016
Q2
$702K Buy
16,452
+8,070
+96% +$328K ﹤0.01% 3652
2016
Q1
$356K Buy
8,382
+349
+4% +$13.6K ﹤0.01% 4044
2015
Q4
$288K Buy
8,033
+1,551
+24% +$55.7K ﹤0.01% 4380
2015
Q3
$239K Sell
6,482
-1,781
-22% -$62.9K ﹤0.01% 4492
2015
Q2
$272K Buy
8,263
+1,599
+24% +$54K ﹤0.01% 4607
2015
Q1
$232K Sell
6,664
-703
-10% -$24.8K ﹤0.01% 4762
2014
Q4
$270K Buy
+7,367
New +$257K ﹤0.01% 4751

Other funds holding UTL

UBS Group's UTL Position: Q1 2026 in Review

UBS Group reduced its Unitil (UTL) stake by 63% in Q1 2026, selling an estimated $2.08M and leaving 24,164 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #5358.

UBS Group first reported a position in UTL in Q4 2014 and has held it in 46 quarters since. The position peaked at $5.48M in Q2 2025. 238 funds tracked by Wall St. Rank hold UTL as of Q1 2026.

  • UBS Group held 24,164 shares of Unitil worth $1.26M as of Q1 2026.
  • UBS Group sold 40,524 Unitil shares in Q1 2026, an estimated $2.08M.
  • Unitil made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5358 holding.
  • UBS Group first reported a position in Unitil in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Unitil position peaked at $5.48M in Q2 2025.
  • 238 funds tracked by Wall St. Rank held Unitil as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.